IDRx
3 known investors
IDRx discovers, develops and delivers medicines and vaccines focused on cancer, HIV, respiratory diseases, and infectious diseases. The company aims to positively impact the health of 2.5 billion people by the end of the decade.
Founders & leadership
TC
Tim ClacksoninA biotech executive whose leadership roles include President and CEO of Theseus Pharmaceuticals and President and Chief Technology Officer at Xilio Therapeutics. He has served on the boards of Elevation Oncology, Forma Therapeutics, MassBio, Kesmalea Therapeutics, and PanTher Therapeutics.
Investors · 3
Funding
SEC filings, press & company announcements$120M disclosed across 1 of 2 rounds · 2024
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does IDRx do?
- IDRx discovers, develops and delivers medicines and vaccines focused on cancer, HIV, respiratory diseases, and infectious diseases. The company aims to positively impact the health of 2.5 billion people by the end of the decade.
- Who are IDRx's investors?
- IDRx's investors include Andreessen Horowitz, Nextech Invest, RA Capital.
- How much funding has IDRx raised?
- IDRx has disclosed $120M raised across 1 of its 2 known rounds.